Jeffrey is a longstanding Wall Street professional with 36 years’ experience as a distressed debt analyst & portfolio manager (Banco Santander and Standard Bank) and, since 2003, as a senior executive in Credit Sales and Trading (RBC, Stifel and GMP). Mr. Engel has significant experience as a principal, and as an adviser, in investing across the capital structure in a wide variety of industries and asset classes, including energy, healthcare, biotech, telecom, and digital assets. He is currently Senior Managing Director of Capital Markets at Ceros Financial Services (FINRA member Firm). In addition, Mr. Engel is a General Partner in the Pangea Blockchain Fund and a Board of Directors Member of Real Brands Inc (OTCMKTS: RLBD) a CBD extraction and branding company. Mr. Engel began his career in 1988 at Drexel Burnham Lambert as an Associate in their M&A Department in New York.

Mr. Engel has a J.D, University of Miami School of Law (’87) and a B.A., Sarah Lawrence College, (’84). He was a Trustee of Sarah Lawrence 2003-06 and was a board member of the Genetic Disease Foundation at Mt. Sinai Hospital, NY 2006-2023.

Maurice is Vice President at Ceros Capital Markets. Maurice is involved in all aspects of the business, from managing client investment portfolios to analyzing new healthcare opportunities.

Prior to joining Ceros Capital Markets, Maurice worked for INSIGHTEC, an incision-less platform that uses acoustic energy to perform brain surgery. Maurice was a Senior Associate on the commercial team, where he built out a strategy to enter Latin America and worked with the largest healthcare systems. In his previous roles, Maurice worked alongside the sales team in sourcing new opportunities and implementing creative financial models. Prior to this experience, Maurice worked for the US Chamber of Commerce on the Latin America team. 

Maurice earned a bachelor’s degree from Colby College, where he double majored in economics and international relations.

Marc Camprubí Artal is Vice President at Ceros Capital Markets. He is involved in all aspects of the business with a focus on legal affairs and international business development.

Prior to joining Ceros Capital Markets Marc was at FedEx as an in-housel for the Latin America and the Caribbean region. Prior to this, he was at an Israeli startup as an in-house counsel.

Marc holds a Bachelor of Laws from the University of Barcelona and a Master of Laws from Fordham Law School in New York City. He is a licensed attorney in the State of Florida.

Mark Goldwasser has worked in Finance based in Wall St for over 40 years. Mark has worked at a variety of Investment Banks including Bear Stearns, Lazard Freres, Jefferies, and ING Barings in leading roles, many as a Managing Director or Executive Vice President.

Mark was responsible for building National Securities into one of the fastest-growing Independent Broker-Dealers and Investment Bank. Mark was CEO of National for 16 years and Executive Chairman of National Holdings Corporation, a Public Co. for over 10 years. As Chairman he was responsible for the acquisition of two other publicly traded financial service companies.

At National Mark was the Co-Founder of Robotic Ventures the countries first VC fund investing in Robotics. One company was iRobot which went public and Z Cat which evolved into Mako Surgical.

Over his long career, Mark has been responsible for raising tens of Billions of dollars in a variety of securities and markets including emerging markets, SPV’s for Unicorns, Fixed Income and Private Venture Equity including Israel.

Mark is currently the CEO of Ceros Financial Services with over $7.5 Billion in Assets.

Mr. Joseph Hain, also known as Joey, serves as Managing Director of Ceros Capital Markets. Prior to Ceros, Mr. Hain was Director of Noble Capital Markets. Mr. Hain also served as Managing Director, Head Trader, and Portfolio Manager at the Lawrence Fund LP, where he oversaw and directed the entire trading and class action lawsuit operation. Mr. Hain is the Co-Founder and Limited Partner at Intrinsic Value Capital LP. Previously, he served as a Portfolio Manager of Robotti & Company, Incorporated, where he managed portfolios of HNW individuals and family businesses as well as served as Portfolio Manager of the Glaubman Rosenberg & Robotti Fund LP. a fundamental value focused hedge fund. Mr. Hain began investment banking in 2008 and served as Senior Vice President at WestPark Capital, Tejas Securities, Wynston Hill Capital Management, and Paulson Investment Company. Mr. Hain was also Senior Vice President at Stern Aegis Ventures an affiliate of Aegis Capital Corp. and worked with both public and private companies as well as institutional, retail and HNW clients globally. Mr. Hain is a recipient of 40 under 40 for M&A and Dealmaking from M & A Advisor, and is on the Regional Board  for The Diabetes Research Institute. Mr. Hain holds the following security designations: Series 7, 63, 65, and 79 FINRA Licenses. Mr. Hain received a Bachelor of Science from the State University of New York at Albany with a core concentration in Biology, Chemistry, and Physics.

Ahmed Gheith currently serves as the Managing Director of Ceros Capital Markets. Prior to this role, he held the position of Vice President in the Capital Markets division at Noble Capital Markets. Ahmed's journey in the Private Equity arena began at Paulson Investment Company, where he quickly became one of the firm's top-producing brokers. Throughout his  career, Ahmed has skillfully nurtured long-lasting relationships with institutional partners, family offices, and High Net Worth investors  domestically and internationally. Additionally, he has played a pivotal role in numerous Investment Banking transactions, contributing to aggregate proceeds in excess of $250 million.

David Rand, MD, is the Director of Innovation and a board-certified practicing cataract and refractive surgeon at Rand Eye Institute, a multi-specialty ophthalmology practice, ambulatory surgical pavilion, and clinical research center. Dr. Rand attained a bachelors of science degree from University of Miami and subsequently attended the Miller School of Medicine at University of Miami. He completed internal medicine internship at Staten Island University Hospital and ophthalmology residency at SUNY Downstate Medical Center.

In addition to performing clinical research, Dr. Rand is dedicated to contributing to the advancement of medicine through biotechnology ventures and as a FINRA-registered investment banking representative and scientific advisor affiliated with Ceros Financial Services. He is the founder of Codecap, LLC, developing therapeutic hypothermia solutions; co-founder of and advisor to IOPtSens, developing a continuous intraocular pressure monitoring system; advisor to NeuroTrigger, LLC, creator of the first blinking pacemaker; and co-founder of Retiya Medical Solutions, among other positions. His hobbies include teaching advanced Talmudic studies, study of ethics and morality, as well as Tae Kwon Do, achieving rank of 2nd degree black belt.

Daniel Steinberg spent the last 5 years as Managing Director for a private family office where he led major investments into more than a dozen early and late stage venture deals. Demonstrating his unique prowess and talent to be awarded allocations in the most desired companies, he deployed more than $100m on behalf of the FO’s main fund and LP’s.

Prior to entering the investing arena, Daniel spent 10 years in the wireless industry engineering trade-in programs for carriers including Verizon, AT&T, T-Mobile, and Sprint. Daniel went on to be the founder and CEO of Buyback Technologies, a reverse logistics and asset recovery startup enabling wireless providers to recover used equipment on demand. As a first to market player, Daniel pioneered and revolutionized what has today become standard industry practice. The company was awarded two original S.O.W. contracts with Sprint and serviced them up until the T-Mobile acquisition.